Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for the development, registration and marketing of perifosine
Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for the development, registration and marketing of perifosine
Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for the development, registration and marketing of perifosine
Submitted by
admin
on March 13, 2011 - 11:30am
Source:
PR-USA.net
News Tags:
Aeterna Zentaris
Yakult
perifosine
oncology
colon cancer
Headline:
Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for the development, registration and marketing of perifosine
Do Not Allow Advertisers to Use My Personal information
